Indirect estimation of reference intervals for thyroid parameters using ADVIA Centaur XP analyser

  • Bosa Mirjanić-Azarić University Clinical Centre of the Republic of Srpska, Department of Clinical Biochemistry
Keywords: reference intervals, indirect methods, thyroid parameters

Abstract


Background: The aim of this study was to determine the reference intervals (RIs) for thyroid stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3) and FT3/FT4 ratio using indirect methods.

Methods: We analysed 1256 results TSH, FT4 and FT3 collected from a laboratory information system between 2017 and 2021. All measurements were performed on a Siemens ADVIA Centaur XP analyser using the chemiluminescent immunoassay. We calculated the values of the 2.5th and 97.5th percentiles as recommended by the IFCC (CLSI C28-A3).

Results: The RIs derived for TSH, FT4, FT3 and FT3/FT4 ratio were 0.34-4.10 mIU/L, 11.3-20.6 pmol/L, 3.5-6.32 pmol/L and 0.21-0.47, respectively. We found a significant difference between calculated RIs for the TSH and FT4 and those recommended by the manufacturer. Also, FT3 values were significantly higher in the group younger than 30 years relative to the fourth decade (5.26 vs. 5.02, p=0.005), the fifth decade (5.26 vs. 4.94, p=0.001), the sixth decade (5.26 vs. 4.87, p˂0.001), the seventh decade (5.26 vs. 4.79, p˂0.001) and the group older than 70 years old (5.26 vs. 4.55, p˂0.001). Likewise, we found for TSH values and FT3 / FT4 ratio a significant difference (p <0.001) between different age groups.

Conclusions: The establishing RIs for the population of the Republic of Srpska were significantly differed from the recommended RIs by the manufacturer for TSH and FT4. Our results encourage other laboratories to develop their own RIs for thyroid parameters by applying CLSI recommendations.

References

1. Demers LM, Spencer CA. Laboratory Medicine Practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13: 3-126.
2. Mirjanic-Azaric B, Jerin A, Radic Z. Thyroid stimulating hormone values of clinical decisions of hypothyroidism measurement by three different automated immunoassays. Scand J Clin Lab Invest 2020; 80:151-155.
3. Thienpont LM, Van Uytfanghe K, Beastall G, et al. Report of the IFCC working group for standardization of thyroid function tests; part 2: free thyroxine and free thiiodothyronine. Clin Chem 2010; 56:912–920.
4. Kazerouni F, Amirrasouli H. Performance characteristics of three automated immunoassays for thyroid hormones. Casp J Int Med 2012; 3:400-404.
5. Hendriks HA, Kortlandt W, Verweij WM. Analytical performance comparison of five new generation immunoassay analyzers. Ned Tijdschr Klin Chem 2000; 25:170-177.
6. CLSI and IFCC. C28-A3 document; Defining, establishing and verifying reference intervals in the clinical laboratory: approved guideline-third edition 2008; 28:1-76.
7. Farrell C J L, Nguyen L. Indirect reference intervals: harnessing the power of stored laboratory data. Clin Biochem Rev 2019; 40: 99-111.
8. Jones GRD, Haeckel R, Loh TP, at al. Indirect methods for reference interval determination - review and recommendations. Clin Chem Lab Med 2018; 57:20-29.
9. Mirjanic-Azaric B, Stojakovic-Jelisavac T, Vukovic B, et al. The impact of time of sample collection on the measurement of thyroid stimulating hormone values in the serum. Clin Biochem 2015; 48:1347-1349.
10. Sikaris K. Physiology and its importance for reference intervals. Clin Biochem Rev 2014; 35:3–14.
11. Wang X, Li Y, Zhai X, et al. Reference intervals for serum thyroid-stimulating hormone based on a recent nationwide cross sectional study and meta-analysis. Front Endocrinol 2021. 12:660277. doi: 10.3389/fendo.2021.660277
12. Milinkovic N, Ignjatovic S, Zarkovic M, et al. Indirect estimation of reference intervals for thyroid. Clin Lab 2014; 60:1083-1089.
13. Arzidech F, Wosniok W, Haeckel R. Indirect reference intervals of plasma and serum thyrotropin (TSH) concentrations from intra-laboratory databases from several German and Italian medical centres. Clin Chem Lab Med 2011; 49:659-664.
14. Katayev A, Balciza C, Seccombe DW. Establishing reference intervals for clinical laboratory test: results is there a better way? Ph Am J Clin Pathol 2010; 133:180-186.
15. Clinical Laboratory Standards Institute (CLSI): Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture: Approved Standard, ed 5, CLSI document H3-A5, Villanova, PA, 2003, CLSI.
16. www.medcalc.org.
17. Solberg HE, Lahti A. Detection of Outliers in Reference Distributions: Performance of Horn’s Algorithm. Clin Chem 2005; 51: 2326-2332.
18. Klee GG, Ichihara K, Ozarda Y, et al. Reference intervals: comparison of calculation methods and evaluation of procedures for merging reference measurements from two US medical centers. Am J Clin Pathol 2018;150:545-554.
19. Ozarda Y, Ichihara K, Bakan E, et al. A nation wide multicentre study in Turkey for establishing reference intervals of haematological parameters with novel use of a panel of whol blood. Biochem Med 2017; 27:350-377.
20. Tozzoli R, D’Aurizio F, Metus P, et al. Reference intervals for thyrotropin in an area of Northern Italy: the Pordenone thyroid study (TRIPP). J Endocrinol Invest 2018; 41:985-994.
21. Ittermann T, Khattak RM, Nauck M, et al. Shift of the TSH reference range with improved iodine supply in Northeast Germany. Eur J Endocrinol 2015; 172:261–267.
22. Ren B, Wan S, Liu L, et al. Distributions of serum thyroidstimulating hormone in 2020 thyroid disease-free adults from areas with different iodine levels: a cross-sectional survey in China. J Endocrinol Invest 2021; 44:1001-1010.
23. Cai J, Fang Y, Jing D, et al. Reference intervals of thyroid hormones in a previously iodine-deficient but presently more than adequate area of Western China: a population-based survey. Endocr J 2016; 63:381-388.
24. O’Leary PC, Feddema PH, Michelangeli VP, et al. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin Endocrinol (Oxf) 2006; 64:97-104.
25. Surks M, Ortiz E, Daniels GH, at al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291:228-238.
26. Spencer CA, Hallowell JG, Kazarosyan M, et al. National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab 2007; 92: 4236-4240.
27. Mirjanic-Azaric B, Avram S, Stojakovic-Jelisavac T, et al. Direct estimation of reference intervals for thyroid parameters in the Republic of Srpska. J Med Biochem 2017; 36:137-144.
28. Lolic A, Prodanovic N. The Republic of Srpska Iodine Deficiency Survey 2006. Hormone 2008; 7: 163-169.
29. Park SY, Kim HI, Oh HK, et al. Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015). PLoS One 2018; 13: e0190738. doi: 10.1371 /journal.pone.0190738
30. Milinkovic N, Ignjatovic S, Zarkovic M, et al. Indirect estimation of age-related reference limits of thyroid parameters: A cross-sectional study of outpatients ’results. Scand J Clin Lab Invest 2014; 74: 378–384.
31. Mariotti S, Franceschi C, Cossarizza A, et al. The aging thyroid. Endocr Rev 1995; 16:686-715.
32. Rozing MP, Westendorp RG, de Craen AJ, et al. Low serum free triiodothyronine levels mark familial longevity: the Leiden Longevity Study. J Gerontol A Biol Sci Med Sci 2010; 65:365-368.
33. Boucai L, Hollowell J, Surks M. An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid 2011; 21:5-11.
34. Thienpont LM, Uytfanghe KV, De Grande LAC, et al. Harmonization of serum thyroid-stimulating hormone measurements paves the way for the adoption of a more uniform reference interval. Clinical Chemistry 2017; 63:1248-1260.
35. Chen X, Zhou Y, Zhou M, et al. Diagnostic values of free triiodothyronine and free thyroxine and the ratio of free triiodothyronine to free thyroxine in thyrotoxicosis. Int J Endocrin 2018: ID 4836736.
36. Park SY, Park SE, Jung SW, et al. Free triiodothyronine/free thyroxine ratio rather than thyrotropin is more associated with metabolic parameters in healthy euthyroid adult subjects. Clin Endocrinol (Oxf) 2017; 87: 87-96.
37. Urrunaga-Pastor D, Guarnizo-Poma M, Moncada-Mapelli E, et al. High free triiodothyronine and free-triiodothyronine-to-free-thyroxine ratio levels are associated with metabolic syndrome in a euthyroid population, Diab Met Syndr: Clin Res Rev 2017; https://doi.org/10.1016/j.dsx.2017.12.003
38. Bahadır ÇT, Yılmaz M, Kılıçkan E. Free triiodothyronine to free thyroxine ratio in the differential diagnosis of thyrotoxicosis and hyperthyroidism: A retrospective study. Int J Clin Pract 2021;75:e14003. doi: 10.1111/ijcp.14003
39. Strich D, Karavani G, Edri S, et al. TSH enhancement of FT4 to FT3 conversion is age dependent. Eur J Endocrinol 2016;175:49-54. doi: 10.1530/EJE-16-0007
40. Štěpánek L, Horáková D, Štěpánek L, et al. Free triiodothyronine/free thyroxine (FT3/FT4) ratio is strongly associated with insulin resistance in euthyroid and hypothyroid adults: a cross-sectional study. Endokrynol Pol 2021;72:8-13. DOI:10.5603/EP.a2020.0066
Published
2021/09/17
Section
Original paper